Literature DB >> 24497208

Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status.

Rosario Pivonello1, Maria Cristina De Martino, Renata S Auriemma, Carlo Alviggi, Ludovica F S Grasso, Alessia Cozzolino, Monica De Leo, Giuseppe De Placido, Annamaria Colao, Gaetano Lombardi.   

Abstract

Pregnancy is becoming a relatively common event in patients with pituitary tumors (PT), due to the increasing availability of medical treatments, which control pituitary diseases associated with the development of PT. However, the presence of PT and its treatment may be a disturbing factor for pregnancy, and pregnancy significantly influences the course and the management of PT. This review summarizes the knowledge about the management of PT during pregnancy and the occurrence of pregnancy in patients with pre-existent PT, focusing on secreting PT characterized by hormonal excess and on clinically non-functioning PT often associated to hormone deficiency, which configure the hypopituitaric syndrome.

Entities:  

Mesh:

Year:  2014        PMID: 24497208     DOI: 10.1007/s40618-013-0019-8

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  87 in total

1.  Follow-up of pregnancy in acromegalic women: different presentations and outcomes.

Authors:  A Atmaca; S Dagdelen; T Erbas
Journal:  Exp Clin Endocrinol Diabetes       Date:  2006-03       Impact factor: 2.949

Review 2.  Growth-hormone and prolactin excess.

Authors:  A Colao; G Lombardi
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

Review 3.  Acromegaly.

Authors:  S Melmed
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

4.  Placental and pituitary growth hormone secretion during pregnancy in acromegalic women.

Authors:  A Beckers; A Stevenaert; J M Foidart; G Hennen; F Frankenne
Journal:  J Clin Endocrinol Metab       Date:  1990-09       Impact factor: 5.958

5.  Cushing's syndrome in pregnancy: the timing of definitive treatment.

Authors:  J S Bevan; M H Gough; M D Gillmer; C W Burke
Journal:  Clin Endocrinol (Oxf)       Date:  1987-08       Impact factor: 3.478

Review 6.  Prolactinoma in pregnancy.

Authors:  Mark E Molitch
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-12       Impact factor: 4.690

7.  Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist.

Authors:  A J van der Lely; R K Hutson; P J Trainer; G M Besser; A L Barkan; L Katznelson; A Klibanski; V Herman-Bonert; S Melmed; M L Vance; P U Freda; P M Stewart; K E Friend; D R Clemmons; G Johannsson; S Stavrou; D M Cook; L S Phillips; C J Strasburger; S Hackett; K A Zib; R J Davis; J A Scarlett; M O Thorner
Journal:  Lancet       Date:  2001-11-24       Impact factor: 79.321

Review 8.  Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature.

Authors:  Sonia Cheng; Ludovica Grasso; Jose A Martinez-Orozco; Rany Al-Agha; Rosario Pivonello; Annamaria Colao; Shereen Ezzat
Journal:  Clin Endocrinol (Oxf)       Date:  2012-02       Impact factor: 3.478

9.  Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage.

Authors:  A Colao; A Di Sarno; M L Landi; S Cirillo; F Sarnacchiaro; G Facciolli; R Pivonello; M Cataldi; B Merola; L Annunziato; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

Review 10.  Cushing's Syndrome.

Authors:  Rosario Pivonello; Maria Cristina De Martino; Monica De Leo; Gaetano Lombardi; Annamaria Colao
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

View more
  5 in total

Review 1.  Visual loss in pregnancy.

Authors:  Caroline Annette Erika Bachmeier; Cameron Snell; Adam Morton
Journal:  BMJ Case Rep       Date:  2019-05-05

Review 2.  Pegvisomant in acromegaly: an update.

Authors:  A Giustina; G Arnaldi; F Bogazzi; S Cannavò; A Colao; L De Marinis; E De Menis; E Degli Uberti; F Giorgino; S Grottoli; A G Lania; P Maffei; R Pivonello; E Ghigo
Journal:  J Endocrinol Invest       Date:  2017-02-07       Impact factor: 4.256

3.  Functioning Endocrine Tumors in Pregnancy: Diagnostic and Therapeutic Challenges.

Authors:  Kripa E Cherian; Nitin Kapoor; Thomas V Paul; Hesarghatta S Asha
Journal:  Indian J Endocrinol Metab       Date:  2021-12-15

4.  Analysis of perioperative negative emotion risk factors in patients with pituitary adenoma and its impact on prognosis: a retrospective study.

Authors:  Guiping Yang; Sen Shen; Jiajia Zhang; Yan Gu
Journal:  Gland Surg       Date:  2022-07

5.  The Incidence of Pregnancy-Associated Cushing's Disease and Its Relation to Pregnancy: A Retrospective Study.

Authors:  Keyun Tang; Lin Lu; Ming Feng; Hanlin Zhang; Kang Chen; Xu Sun; Huijuan Zhu; Renzhi Wang; Zhaolin Lu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-29       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.